FDA Approves PRAVASTATIN SODIUM — Amici Pharma, Inc.
Amici Pharma received FDA approval on February 11, 2008, for Pravastatin Sodium Tablets, providing a new generic entry into the cholesterol-lowering market. The launch is expected to intensify price competition within the statin sector, challenging established branded and generic manufacturers.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day